An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus

ABSTRACT Influenza virus infections are a global public health problem, with a significant impact of morbidity and mortality from both annual epidemics and pandemics. The current strategy for preventing annual influenza is to develop a new vaccine each year against specific circulating virus strains...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Louis M. Schwartzman, Andrea L. Cathcart, Lindsey M. Pujanauski, Li Qi, John C. Kash, Jeffery K. Taubenberger
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2015
Materias:
Acceso en línea:https://doaj.org/article/cea1cc51d5b54d1b8b118a8c21c76d8d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cea1cc51d5b54d1b8b118a8c21c76d8d
record_format dspace
spelling oai:doaj.org-article:cea1cc51d5b54d1b8b118a8c21c76d8d2021-11-15T15:41:25ZAn Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus10.1128/mBio.01044-152150-7511https://doaj.org/article/cea1cc51d5b54d1b8b118a8c21c76d8d2015-09-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01044-15https://doaj.org/toc/2150-7511ABSTRACT Influenza virus infections are a global public health problem, with a significant impact of morbidity and mortality from both annual epidemics and pandemics. The current strategy for preventing annual influenza is to develop a new vaccine each year against specific circulating virus strains. Because these vaccines are unlikely to protect against an antigenically divergent strain or a new pandemic virus with a novel hemagglutinin (HA) subtype, there is a critical need for vaccines that protect against all influenza A viruses, a so-called “universal” vaccine. Here we show that mice were broadly protected against challenge with a wide variety of lethal influenza A virus infections (94% aggregate survival following vaccination) with a virus-like particle (VLP) vaccine cocktail. The vaccine consisted of a mixture of VLPs individually displaying H1, H3, H5, or H7 HAs, and vaccinated mice showed significant protection following challenge with influenza viruses expressing 1918 H1, 1957 H2, and avian H5, H6, H7, H10, and H11 hemagglutinin subtypes. These experiments suggest a promising and practical strategy for developing a broadly protective “universal” influenza vaccine. IMPORTANCE The rapid and unpredictable nature of influenza A virus evolution requires new vaccines to be produced annually to match circulating strains. Human infections with influenza viruses derived from animals can cause outbreaks that may be associated with high mortality, and such strains may also adapt to humans to cause a future pandemic. Thus, there is a large public health need to create broadly protective, or “universal,” influenza vaccines that could prevent disease from a wide variety of human and animal influenza A viruses. In this study, a noninfectious virus-like particle (VLP) vaccine was shown to offer significant protection against a variety of influenza A viruses in mice, suggesting a practical strategy to develop a universal influenza vaccine.Louis M. SchwartzmanAndrea L. CathcartLindsey M. PujanauskiLi QiJohn C. KashJeffery K. TaubenbergerAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 6, Iss 4 (2015)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Louis M. Schwartzman
Andrea L. Cathcart
Lindsey M. Pujanauski
Li Qi
John C. Kash
Jeffery K. Taubenberger
An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
description ABSTRACT Influenza virus infections are a global public health problem, with a significant impact of morbidity and mortality from both annual epidemics and pandemics. The current strategy for preventing annual influenza is to develop a new vaccine each year against specific circulating virus strains. Because these vaccines are unlikely to protect against an antigenically divergent strain or a new pandemic virus with a novel hemagglutinin (HA) subtype, there is a critical need for vaccines that protect against all influenza A viruses, a so-called “universal” vaccine. Here we show that mice were broadly protected against challenge with a wide variety of lethal influenza A virus infections (94% aggregate survival following vaccination) with a virus-like particle (VLP) vaccine cocktail. The vaccine consisted of a mixture of VLPs individually displaying H1, H3, H5, or H7 HAs, and vaccinated mice showed significant protection following challenge with influenza viruses expressing 1918 H1, 1957 H2, and avian H5, H6, H7, H10, and H11 hemagglutinin subtypes. These experiments suggest a promising and practical strategy for developing a broadly protective “universal” influenza vaccine. IMPORTANCE The rapid and unpredictable nature of influenza A virus evolution requires new vaccines to be produced annually to match circulating strains. Human infections with influenza viruses derived from animals can cause outbreaks that may be associated with high mortality, and such strains may also adapt to humans to cause a future pandemic. Thus, there is a large public health need to create broadly protective, or “universal,” influenza vaccines that could prevent disease from a wide variety of human and animal influenza A viruses. In this study, a noninfectious virus-like particle (VLP) vaccine was shown to offer significant protection against a variety of influenza A viruses in mice, suggesting a practical strategy to develop a universal influenza vaccine.
format article
author Louis M. Schwartzman
Andrea L. Cathcart
Lindsey M. Pujanauski
Li Qi
John C. Kash
Jeffery K. Taubenberger
author_facet Louis M. Schwartzman
Andrea L. Cathcart
Lindsey M. Pujanauski
Li Qi
John C. Kash
Jeffery K. Taubenberger
author_sort Louis M. Schwartzman
title An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
title_short An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
title_full An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
title_fullStr An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
title_full_unstemmed An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
title_sort intranasal virus-like particle vaccine broadly protects mice from multiple subtypes of influenza a virus
publisher American Society for Microbiology
publishDate 2015
url https://doaj.org/article/cea1cc51d5b54d1b8b118a8c21c76d8d
work_keys_str_mv AT louismschwartzman anintranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT andrealcathcart anintranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT lindseympujanauski anintranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT liqi anintranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT johnckash anintranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT jefferyktaubenberger anintranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT louismschwartzman intranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT andrealcathcart intranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT lindseympujanauski intranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT liqi intranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT johnckash intranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
AT jefferyktaubenberger intranasalviruslikeparticlevaccinebroadlyprotectsmicefrommultiplesubtypesofinfluenzaavirus
_version_ 1718427729674633216